Organisms | Evidence |
---|---|
Severe acute respiratory syndrome coronavirus 2 |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O15455 | Toll-like receptor 3 | ||
A0A087WRT4 | FAT atypical cadherin 1 | ||
A0PJK1 | Sodium/mannose cotransporter SLC5A10 | ||
A2ASS6 | Titin | ||
A2BE28 | Ribosomal biogenesis protein LAS1L | ||
A2VD12 | Pre-B-cell leukemia transcription factor-interacting protein 1 | ||
A8MVW5 | HEPACAM family member 2 | ||
B0V2N1 | Receptor-type tyrosine-protein phosphatase S | ||
B1AUH1 | Receptor-type tyrosine-protein phosphatase U | ||
B2GV54 | Neutral cholesterol ester hydrolase 1 |
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
37074911 | Integrated glycoproteomic characterization of clear cell renal cell carcinoma | Lih T Mamie | 2023-05-30 |
|
34004174 | Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells | Parker R | 2021 May 25 |
|
34089345 | Tumor cells express pauci- and oligomannosidic N-glycans in glycoproteins recognized by the mannose receptor (CD206) | Stavenhagen K | 2021 Jul |
|
34106099 | N-Glycosylation in isolated rat nerve terminals | Matthies I | 2021 Aug 1 |
|
33077685 | Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins | Zhang Y | 2021 |
|
32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
33064451 | Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry | Wang D | 2020 Nov 3 |
|
32363391 | Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 | Shajahan A | 2020 May 4 |
|
32366695 | Site-specific glycan analysis of the SARS-CoV-2 spike | Watanabe Y | 2020 May 4 |
|
32518941 | Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics | Zhou D | 2020 Jun 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025